Sort
261,768 grants matching “gene therapy”
Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency
$2,089,212David J Rawlings · Seattle Children'S Hospital · P01 · FY2013 · AI
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,089,144Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Inner ear gene therapy program
$2,089,011Ronna Hertzano · National Institute On Deafness And Other Communication Disorders · ZIA · FY2025 · DC
Costimulatory Mechanisms of Autoimmunity (Composite)
$2,088,964David A. Hafler · Yale University · P01 · FY2014 · AI
THERAPY OF CML
$2,088,460University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
Center for the Biologic Basis of Oral/Systemic Disease (CBBOSD)
$2,088,426Jeffrey L Ebersole · University Of Kentucky · P20 · FY2013 · GM
SPORE in Brain Cancer
$2,088,365Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
The Co-Clinical Project: Informing clinical trials using preclinical mouse models
$2,088,292Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · RC2 · FY2010 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,088,156Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SPORE in Breast Cancer
$2,088,032Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2020 · CA
Pachyonychia congenita clinical trial using therapeutic self-delivery siRNAs
$2,087,970Roger L Kaspar · Transderm, Inc. · R44 · FY2011 · AR
MIT Center for Integrative Synthetic Biology
$2,087,772Ron Weiss · Massachusetts Institute Of Technology · P50 · FY2014 · GM
Topology of Cancer Evolution and Heterogeneity
$2,087,754Raul Rabadan · Columbia University Health Sciences · U54 · FY2017 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
$2,087,361Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2018 · CA
Molecular pathological epidemiology of colorectal cancer
$2,086,962Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
Prospective Study of Breast Cancer Survivorship
$2,086,761Lawrence H Kushi · Kaiser Foundation Research Institute · R01 · FY2010 · CA
Integrative Oncogenomics of Multiple Myeloma
$2,086,676Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Understanding Frontotemporal Dementia Using Drosophila and iPSC Models
$2,086,468Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · RF1 · FY2022 · NS
Role of NOD2 Variants in Eosinophilic Esophagitis
$2,086,360Tetsuo Shoda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · DK
MANUFACTURING OF PLASMID AND VECTOR AND GLP DOSE-ESCALATION TOXICOLOGY STUDIES IN NORMAL RATS AND NORMAL NHPS
$2,086,305Amanda Burnaugh · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2023 · DA
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,086,208Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2012 · GM
PIDTC Administrative Unit
$2,086,129Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2022 · AI
Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses
$2,085,765Garth Powis · Phusis Therapeutics, Inc. · R44 · FY2025 · CA
MicroRNAs for therapy of visual disorders
$2,085,203Martin Friedlander · Scripps Research Institute, The · R24 · FY2013 · EY
CAR-T Therapy of Mesothelin Expressing Cancers
$2,085,050Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA